Skip to content
Home/Companies/Biotech/Metabogen

Metabogen

Biotech·Sweden·Exited 2021·Held 10yr
Entry
2011
Hold
10yr
Exit
2021

Who owns Metabogen?

Metabogen was owned by GU Ventures through GU Ventures Evergreen (1995 vintage) from 2011 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-17

GU Ventures
Investor
GU Ventures
GU Ventures Evergreen · 1995 · VC

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from GU Ventures Evergreen

Other portfolio companies in the same fund.

Mucolife Therapeutics
Active
BiotechSweden· 2024
Pretzel Therapeutics
Pretzel Therapeutics
Active
BiotechUS· 2022
dpella
Active
Data & AnalyticsSweden· 2021
Nanolyze
Active
Deep TechSweden· 2020
SimSen Diagnostics
Active
MedTechSweden· 2020
Hydroc Energy Storage
Active
EnergySweden· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Metabogen

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Metabogen?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Metabogen.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue